19 Nov 2018 | 8:06 PM
 

Bafna Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532989 | NSE Symbol: BAFNAPHARM
14.69
0.39
(2.73 %)
15 Nov 2018 | 03:41 PM
Change company
  • Open (Rs)
    13.60
  • Prev. close (Rs.)
    14.30
  • High (Rs.)
    14.69
  • Low (Rs.)
    13.60
  • 52W H (Rs.)
    30.35
  • 52W L (Rs.)
    10.91
  • Volume
    346
  • MCap (Rs in Cr.)
    34.76
No Data Available
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
-7.07
Operating Margin (%)
-74.47
Gross Profit Margin (%)
-82.89
Net Profit Margin (%)
-35.48
Total Debt/Equity
1.23
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
0.00

News

29 May 2018 - 13:00:00-The company reported standalone net loss during the quarter stood at Rs 34...
10 Nov 2017 - 18:32:00-The company reported standalone net loss during the quarter stood at Rs 2...
08 Aug 2017 - 19:55:00-The company reported standalone net loss during the quarter stood at Rs 7...
08 Aug 2017 - 19:55:00-The company reported standalone net loss during the quarter stood at Rs 7...

Announcements

13-Nov-2018
Bafna Pharmaceutical - Result For 30Th Sep 2018
13-Nov-2018
Bafna Pharmaceutical - Outcome of Board Meeting
05-Nov-2018
Bafna Pharmaceutical - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Inter-Alia Consider And App
24-Oct-2018
Bafna Pharmaceutical - Ref: Regulation 40(9) Of The SEBI (LODR) Regulations 2015
16-Oct-2018
Bafna Pharmaceutical - Shareholding for the Period Ended September 30 2018

Religare Research

19 Nov 2018 | 07:00 AM
We maintain our cautious view on markets and suggest booking profit on every rise, citing major hurd...
16 Nov 2018 | 07:00 PM
Incorporated in 1962, Tata Global Beverages Ltd is amongst the world's largest tea companies along w...
16 Nov 2018 | 07:00 PM
Nifty managed to end in green for the third successive week amid volatility and settled at 10,682.20...
16 Nov 2018 | 03:05 PM
Reliance Nippon Life Asset Management (RNAM) reported a net profit growth of 10.4% YoY at Rs. 111 cr...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

      
Promotors26.36%
Mutual Funds/UTI0.00%
FI/Banks0.00%
Insurance0.00%
FII0.00%
Government0.00%
Others11.94%

Peer Group

Company Intraday Graph
 Hester Biosciences Ltd.
1,135.65(-0.34)
3572
 DIL Ltd.
990.00(3.69)
3299
 TTK Healthcare Ltd.
790.05(0.64)
3392
 Novartis India Ltd.
700.90(-0.44)
2647

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Bafna Pharmaceuticals Ltd.3.24-5.86-10.56
NIFTY(S&P CNX)178.65-621.6522.30
BSE SENSEX612.40-1,888.68387.00
BSE 500234.43-1,014.69-455.35

Corporate Details

Key Personal
B Kamlesh Kumar
Ind. Non-Executive Director
Bafna Mahaveer Chand
Chairman & Managing Director
K Sabitha
Non Ind.& Exe.Director
Key Address
Registered Office
Bafna Towers New?No.?68 ?Old?No. 299 ?? ? Thambu Chetty Street,Chennai (Madras),Tamil Nadu

Tel:044-25267517 42677555 25270992, Fax:044-25231264

info@bafnapharma.com
http://www.bafnapharma.com
Registrar Office
Cameo Corporate Services Ltd.
Add. :Subramanian Building No.1 Vth Floor Club House Road